<DOC>
	<DOCNO>NCT02074566</DOCNO>
	<brief_summary>Cryoballoon base therapy establish therapy treatment ( paroxysmal ) atrial fibrillation . However , rapid evolution cryoablation technique increase effectiveness , risk complication increase . Therefore utmost importance define optimal duration cryoballoon ablation time.The objective study ass optimal ablation duration use second generation cryoballoon isolation pulmonary vein treatment atrial fibrillation .</brief_summary>
	<brief_title>Defining Optimal Cryoballoon Duration Therapy Treatment Atrial Fibrillation : Defining Optimal Cryoballoon Duration Therapy Treatment Atrial Fibrillation : The 1-2-3 Study</brief_title>
	<detailed_description>Rationale Cryoballoon base therapy establish therapy treatment ( paroxysmal ) atrial fibrillation . However , rapid evolution cryoablation technique increase effectiveness , risk complication increase . Therefore utmost importance define optimal duration cryoballoon ablation time . Objective To assess optimal ablation duration use second generation cryoballoon isolation pulmonary vein treatment atrial fibrillation . Study design The study design prospective multicentre randomize efficacy study . Study population Patients 18-70 year age paroxysmal atrial fibrillation eligible pulmonary vein isolation accord current international guideline . Intervention Patients randomize 2 cycle 1 , 2 3 minute cryoballoon ablation reach temperature `` plateau phase '' . Main study parameters/endpoints Acute success pulmonary vein isolation . Nature extent burden risk associate participation , benefit group relatedness : No additional risk present procedure common clinical practice , current cryoballoon application time 3 minute Shorter application time expect add risk .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Paroxysmal atrial fibrillation eligible pulmonary vein isolation accord current international guideline . Age &lt; 70 year . Willing able sign inform consent . Willing capable follow request study procedure . Age &lt; 18 year . Pregnancy Life followup expectancy &lt; 12 month . Previous PVI . Contrast allergy . Creatin clearance level &lt; 60 . Left ventricular ejection fraction &lt; 40 % Abnormal leave atrium anatomy define number PV 's â‰  4 Left Atrium diameter &gt; 50mm ( measure parasternal long axis , assess transthoracic echocardiography ) &gt; 40 cc/m2 . This lead exclusion inclusion randomisation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Pulmonary Vein Isolation</keyword>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Cryoballoon therapy</keyword>
	<keyword>Duration</keyword>
</DOC>